OCD drug safety trial halted early
Disease control
Terminated
This study looked at the long-term safety of a drug called troriluzole for people with obsessive-compulsive disorder (OCD) who didn't get enough help from standard treatments. About 772 adults were expected to join, but the study was stopped early. The goal was to see if the drug…
Phase: PHASE3 • Sponsor: Biohaven Pharmaceuticals, Inc. • Aim: Disease control
Last updated May 13, 2026 15:59 UTC